BET-EFF (MV-4-11): Sacrificing 2 Sick Mice – Tumor Burden

Slides:

Advertisements

Similar presentations

Incomplete Treatment Complete Treatment Control Flow Cytometric Cell Cycple Analysis of Propidium Iodide-Stained HPAC Cells ControlComplete TreatmentIncomplete.

Advertisements

Supplementary Figure S1.

Cell Physiol Biochem 2013;32: DOI: /

G1 synchronous cells released at T = 0

BET-EFF (MV-4-11): Sacrificing 4 Sick Mice – Tumor Burden

Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in.

Figure S2 apoptosis-PARP -WB

BM SPL PB Beads & Nucleated HLA-ABC+ Beads & Nucleated HLA-ABC+

Drug concentration (μM)

Volume 10, Issue 4, Pages (October 2006)

Anti-CD40 and CpG induce activation of T cells in draining lymph nodes

Online Gifts Buy for wishes happy mother's day to yours choice and with happy gifts find here:

Volume 21, Issue 12, Pages (December 2017)

A surrogate marker to monitor angiogenesis at last

TRF2ΔBΔM induces apoptosis and senescence in the mouse liver.

Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a γ-Secretase Inhibitor in Gastric Cancer Muxing Kang, Yaoyi Zhang,

A B A B C Supplementary Fig. 8 Supplementary Fig. 9

Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.

B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality by Rachelle G. Veenstra, Ryan Flynn, Katharina.

Xuesong Wu, Timothy W. Wang, George M

Supplementary Fig. 1 Co-treatment inhibited Ki67 expression.

A B C D E F Supplementary Fig. 1. Gating strategy for CD44+CD133+CD24+ B16 tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells.

A B C D E F Supplementary Fig. 2. Gating strategy for CD44+CD24+ ID8agg tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells were.

Effects of AG-221 treatment on survival and cell differentiation in an IDH2R140Q primary human AML xenograft model. Effects of AG-221 treatment on survival.

Respiratory Virus-Induced Dysregulation of T-Regulatory Cells Leads to Chronic Rejection Ankit Bharat, MD, Elbert Kuo, MD, Deepti Saini, PhD, Nancy Steward,

Pak2 regulates myeloid-derived suppressor cell development in mice

Volume 6, Issue 1, Pages (January 2014)

BV6 increases tumor burden in bone.

Supplementary Figure text

Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia by Parvathi Ranganathan, Xueyan Yu, Caroline Na, Ramasamy Santhanam, Sharon Shacham,

Figure 2S (Supplementary Data)

Xuesong Wu, Timothy W. Wang, George M

Carla Olivares, M. Sc. , Analía Ricci, M. Sc. , Mariela Bilotas, Ph. D

DQ661 improves survival in colon cancer model and potentiates activity of gemcitabine in KPC pancreatic cancer syngeneic model. DQ661 improves survival.

Volume 140, Issue 1, Pages e3 (January 2011)

Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer

The BET inhibitor JQ‐1 in combination with the MEK inhibitor PD synergistically impairs cell proliferation and induces apoptosis of NRAS‐mutant.

Volume 21, Issue 8, Pages (November 2017)

Effect of OPN on apoptosis of DCs

Cisplatin augments cytotoxic T-lymphocyte–mediated antitumor immunity in poorly immunogenic murine lung cancer Robert E Merritt, MD, Ali Mahtabifard,

Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells by Xiaoli Wang, Cing Siang Hu, Bruce Petersen, Jiajing.

Histological changes in mouse colons after DSS treatment.

Volume 6, Issue 1, Pages (January 2014)

DeathPro dyes Hoechst and PI do not affect organoid growth and drug responses DeathPro dyes Hoechst and PI do not affect organoid growth and drug responses.

Volume 4, Issue 2, Pages (February 2009)

CXCR5 expression accelerates Eμ-Tcl1 leukemogenesis and is indispensable for tumor cell recruitment to lymphoid B-cell follicles. CXCR5 expression accelerates.

by Pamela J. Sung, Mayumi Sugita, Holly Koblish, Alexander E

Fig. 3. Effects of Tec on IL-1β-induced apoptosis in chondrocytes.

Volume 8, Issue 2, Pages (August 2003)

Figure 1. Effects of Gal-4 on apoptosis and proliferation of monocytes

Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.

Protection from 4T1 tumor rechallenge in treated mice.

Supplementary figure 1 A B Water (Control) Pre-alcohol Post-alcohol

Figure 5. Hematopoietic cell specific Atg5 deficiency results in aberrant proliferation and mitochondrial dysfunction in hematopoietic cells. (A) Apoptosis.

Effect of HA on hematopoietic recovery in tumor-bearing mice.

Β-Cryptoxanthin at a concentration of 10 μmol/L decreases proliferation in HCT116 cells after 6 and 8 days of treatment. β-Cryptoxanthin at a concentration.

Volume 7, Issue 2, Pages (February 2003)

Vascular staining in CWR22R xenograft tumors.

Effect of IL24 on phosphorylation of eIF2α and proliferation in cancer cells. Effect of IL24 on phosphorylation of eIF2α and proliferation in cancer cells.

Antitumor effects of celastrol in vitro and in vivo.

In vivo AraC treatment does not induce any consistent changes in CD34+/−CD38+/− phenotypes nor in quiescent leukemic cells but increases apoptotic cell.

Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,

ESKM treatment does not affect leukocyte or HSC counts in HLA-A

Inhibition of spontaneous pulmonary metastasis and prolonged survival after removal of primary tumor and intratracheal delivery of rAAV2/5-VAS. Inhibition.

Effect of BCAA on the progression of cell cycle, expression of p21CIP1, and induction of apoptosis in HepG2 cells in the presence and absence of visfatin.

Cabozantinib causes significant tumor cell elimination in vivo, but modest apoptosis induction in vitro. Cabozantinib causes significant tumor cell elimination.

GCS-100 selectively kills KRAS-addicted lung tumors.

BH3-targeted inhibitors drive specific resistance in human cell lines, which can be overcome with alternating or combining inhibitors. BH3-targeted inhibitors.

B-cell development in young Pax5+/− mice.

Bezafibrate increases the number of effector CTLs by enhancing their survival capacity and proliferation. Bezafibrate increases the number of effector.

Presentation transcript:

BET-EFF (MV-4-11): Sacrificing 2 Sick Mice – Tumor Burden (5/31/16 – Day 17 of Drug Treatment) Beads & Nucleated Cells HLA-ABC BM 5160 5155 SPL PB 5155 5160 Isotype Control HLA-ABC Staining

BET-EFF (MV-4-11): Sacrificing 2 Sick Mice – Apoptosis Assay (5/31/16 – Day 17 of Drug Treatment) HLA-ABC+ Annexin V vs PI BM 5160 5155 SPL PB Isotype Control HLA-ABC Staining

BET-EFF (MV-4-11): Sacrificing 2 Sick Mice – Apoptosis Assay (5/31/16 – Day 17 of Drug Treatment) PI- Live Cells Nucleated Cells BM 5160 5155 SPL PB Isotype Control HLA-ABC Staining

BET-EFF (MV-4-11): Sacrificing 2 Sick Mice – Apoptosis Assay (5/31/16 – Day 17 of Drug Treatment) Nucleated Cells HLA-ABC+ BM 5160 5155 SPL PB Isotype Control HLA-ABC Staining